Vol. 29 (2) 2022 – 05

Comparison of Histidine rich glycoprotein, a novel biomarker for sepsis, with traditional biomarkers in adult ICU patients The Egyptian Journal of Immunology Volume 29 (2), April, 2022 Pages: 41–47. www.Ejimmunology.org https://doi.org/10.55133/eji.290205 Mohammed A....

Vol. 29 (2) 2022 – 04

Serum clusterin as a promising diagnostic and prognostic marker for hepatocellular carcinoma after locoregional treatment The Egyptian Journal of Immunology Volume 29 (2), April, 2022 Pages: 26–40. www.Ejimmunology.org https://doi.org/10.55133/eji.290204 Hany S....

Vol. 29 (2) 2022 – 03

Assessment of angiotensin converting enzyme gene polymorphism in patients with psoriasis The Egyptian Journal of Immunology Volume 29 (2), April, 2022 Pages: 19–25. www.Ejimmunology.org https://doi.org/10.55133/eji.290203 Nagwa I. Ashry1, Fadia M. Attia2, Amal H....

Vol. 29 (2) 2022 – 02

Association between circulating MicroRNAs (hsa-miR-92a-1* and hsa-miR-454) and multiple sclerosis phenotypes and activity statu The Egyptian Journal of Immunology Volume 29 (2), April, 2022 Pages: 10–18. www.Ejimmunology.org https://doi.org/10.55133/eji.290202 Amira...

Vol. 29 (2) 2022 – 01

Polymorphism in promotor region of IL6 gene as a predictor for severity in COVID -19 patients The Egyptian Journal of Immunology Volume 29 (2), April, 2022 Pages: 01–09. www.Ejimmunology.org https://doi.org/10.55133/eji.290201 Shaimaa A. A. Aladawy1, Lamiaa A. Adel1,...